[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$actu](/topic/$actu) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "We are highly encouraged by the responses observed in refractory and resistant Ewing Sarcoma a disease where treatment options are extremely limited beyond frontline chemotherapy said Daniel Schmitt President & CEO of Actuate. Learn more: $ACTU" [@ActuateThera](/creator/x/ActuateThera) on [X](/post/tweet/1946249916910543306) 2025-07-18 16:45:14 UTC XX followers, XX engagements "$ACTU New alerts have been Posted In the last hours" [@ELISARO34833753](/creator/x/ELISARO34833753) on [X](/post/tweet/1946234170923180504) 2025-07-18 15:42:40 UTC XXX followers, XXX engagements "Dr. Andrew Mazar Actuates Scientific Co-founder and COO highlights the Company's positive Phase X trial results positioning elraglusib a potential first-in-class therapy option for patients with refractory and resistant EWS. $ACTU" [@ActuateThera](/creator/x/ActuateThera) on [X](/post/tweet/1946227277743731149) 2025-07-18 15:15:16 UTC XX followers, XX engagements "🌹 🎊 🔥 🌐 I made $17300 this week with the help of @m3m3k45. Their strategy is simple to understand and works great. Awesome $NVDA $TSLA $AMZN $PLTR $AAPL $MIRA $AIRE $NCL $AEBI $XPOF $MINM $MDBH $ZBAO $SCWO $TELO $BZAI $TLN $VLCN $STRS $MC $WTFC $FSI $ACTU" [@lyndon98633](/creator/x/lyndon98633) on [X](/post/tweet/1946222859212472643) 2025-07-18 14:57:43 UTC X followers, X engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"We are highly encouraged by the responses observed in refractory and resistant Ewing Sarcoma a disease where treatment options are extremely limited beyond frontline chemotherapy said Daniel Schmitt President & CEO of Actuate. Learn more: $ACTU"
@ActuateThera on X 2025-07-18 16:45:14 UTC XX followers, XX engagements
"$ACTU New alerts have been Posted In the last hours"
@ELISARO34833753 on X 2025-07-18 15:42:40 UTC XXX followers, XXX engagements
"Dr. Andrew Mazar Actuates Scientific Co-founder and COO highlights the Company's positive Phase X trial results positioning elraglusib a potential first-in-class therapy option for patients with refractory and resistant EWS. $ACTU"
@ActuateThera on X 2025-07-18 15:15:16 UTC XX followers, XX engagements
"🌹 🎊 🔥 🌐 I made $17300 this week with the help of @m3m3k45. Their strategy is simple to understand and works great. Awesome $NVDA $TSLA $AMZN $PLTR $AAPL $MIRA $AIRE $NCL $AEBI $XPOF $MINM $MDBH $ZBAO $SCWO $TELO $BZAI $TLN $VLCN $STRS $MC $WTFC $FSI $ACTU"
@lyndon98633 on X 2025-07-18 14:57:43 UTC X followers, X engagements
/topic/$actu/posts